Based on 3 analysts giving stock ratings to Microbot Medical Inc in the past month.
In the current month, MBOT has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MBOT average Analyst price target in the last month is 6.667.
Based on analysts' estimates, MBOT EPS is projected to reach -0.080 in FY2026Q3, following reported EPS of -0.084 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.08, while Microbot Medical IncMBOT's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.08.